Loading...

293 posters, 56 videos, 24 topics, 13 sessions, 658 authors, 215 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

ISMICS 2025 Annual Meeting

28 - 31 May, 2025 | Istanbul, Turkey

ISMICS 2025 Annual Meeting banner

P90

Technique And Outcomes Of A Reinforced Robotic Ivor-lewis Esophagectomyanastomosis

Part of Topic

Thoracic

Technique and Outcomes of a Reinforced Robotic Ivor-Lewis Esophagectomy Anastomosis

 Camille Yongue MD,, Michael Zervos MD, Costas Bizekis MD

NYU Langone Health, Department of Cardiothoracic Surgery, Division of Thoracic Surgery

 

Goal: 

To share our technique for a reinforced Ivor Lewis Esophageal robotic anastomosis as well as short term results.

 

Methods: 

Consecutive series of adult patients from Jan. 2021 to Dec. 2024 who underwent robotic Ivor-Lewis esophagectomy by a two-surgeon thoracic team.

In all cases, the anastomosis was characterized by:

-Securing the gastric conduit to the posterior pleura to reduce tension.

-Two running barbed 3-0 sutures.
-Circumferentially wrapping with omentum.
-A posteriorly placed soft drain for daily amylase levels
 

Figure 1: Robotic Port Placement for the Right Chest

 

Figure 2: Key aspects of robotic Ivor-Lewis anastomotic technique:

 a)Medial pleural tacking suture

b) Tacking the esophagus to the gastric conduit

c) The proximal esophagus transected with gastrotomy

d) Stapled posterior anastomosis

e) Passing NGT from above

f) 3-0 Barbed sutures run from the posterior wall

g) Tying the anastomosis

h) Wrapping with omental fat

i) Posterior blake

 

Results: 

• 36 patients (29 men, median age: 70 years)
•34 patients had esophageal cancer
•29 had adenocarcinoma
•4 had squamous cell carcinoma
•2 had benign disease
•80% underwent pre-operative neoadjuvant chemo and radiotherapy
•Median operative time was 241 minutes
•Median blood loss was 60 cc’s
•Average number of lymph nodes removed was 19.
•No conversions from a robotic abdominal and thoracic platform.
•The median length of stay was 5 days.
•There were no anastomotic leaks by amylase levels and/or on post-operative esophagram performed on post-op day 3.
•There was no 30 nor 90-day mortalities.
•29% had complete pathologic response.
 

Conclusions:

Our innovative, single layer, hand-sewn, reinforced and tension-free running anastomosis for robotic Ivor-Lewis esophagectomy can be used for both esophageal cancer and benign disease with excellent results. This approach is easy to teach and is reproducible.

ismics2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.